Trial intelligence / Profile preview

Local Tranexamic Acid in Vaginal Hysterectomy

NCT04760301Recruiting

Sponsor
Meir Medical Center
Start
Feb 2021
Primary completion
Jul 2025
Modality
Small Molecules
Countries
1
01

Overview

Randomised trial of tranexamic acid in hemorrhage (2 arms), sponsored by Meir Medical Center. Primary endpoint: Blood loss during operation. Started Feb 2021; status: recruiting.

02

Drugs

tranexamic acid
03

Conditions

hemorrhage

Beyond the preview

Go deeper on NCT04760301.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04760301.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call